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BACKGROUND AND PURPOSE
Cardiovascular risk is higher in men and postmenopausal women compared with premenopausal women. This may be due to
sex differences in endothelial function. Here, sex differences in endothelial function of porcine coronary arteries (PCAs) were
investigated.
EXPERIMENTAL APPROACH
Distal PCAs were studied under myographic conditions and after precontraction with U46619. Concentration-response curves
to bradykinin were constructed in the presence of a range of inhibitors.
KEY RESULTS
In male and female PCAs, bradykinin produced comparable vasorelaxant responses. Inhibition of NO and prostanoid synthesis
produced greater inhibition in males compared with females. Removing H2O2 with PEG-catalase reduced the maximum
relaxation in the absence, but not the presence of L-NAME and indomethacin in females, and had no effect in males.
Blocking gap junctions with 100 µM carbenoxolone or 18α-glycyrrhetinic acid further inhibited the endothelium-derived
hyperpolarization (EDH)-mediated response in females but not in males. In female PCAs, the maximum EDH-mediated
response was reduced by inhibiting SKCa with apamin and by inhibiting IKCa with TRAM-34, or with both. In male PCAs, at
maximum bradykinin concentration, the EDH-mediated response was reduced in the presence of apamin but not TRAM-34.
Western blot did not detect any differences in connexins 40 or 43 or in IKCa expression between male and female PCAs.
CONCLUSIONS AND IMPLICATIONS
H2O2 mediated some part of endothelium-dependent vasorelaxation in female PCAs and EDH was more important in females,
with differences in the contribution of gap junctions and IKCa channels. These findings may contribute to understanding
vascular protection in premenopausal women.
Abbreviations
18α-GA, 18α-glycyrrhetinic acid; Cx, connexin; EDH, endothelium-derived hyperpolarization; IKCa, intermediate-
conductance calcium-activated K+ channel; MEGJs, myoendothelial gap junctions; PCA, porcine coronary arterie;
PEG-catalase, polyethelene glycol-catalase; SKCa, small-conductance calcium-activated K+ channel; SOD, superoxide
dismutase; U46619, 9,11-dideoxy-9a,11a-epoxymethanoprostaglandin F2α
BJP British Journal ofPharmacology
DOI:10.1111/bph.12595
www.brjpharmacol.org
British Journal of Pharmacology (2014) 171 2751–2766 2751© 2014 The British Pharmacological Society
Introduction
Regulation of vascular tone is controlled by endothelium-
derived relaxants including NO (Furchgott and Zawadzki,
1980), prostacyclin (Moncada et al., 1976) and endothelium-
dependent hyperpolarization (EDH)-type mechanisms (Taylor
and Weston, 1988; Edwards et al., 2010; Feletou and
Vanhoutte, 2013). Many mediators have been proposed to be
responsible for EDH over the past decade, yet none has
appeared to be a ‘universal EDH’ (Griffith, 2004). However, in
2010, the EDH-mediated responses were classified into two
categories (Edwards et al., 2010): the first category is the ‘clas-
sical’ EDH pathway in which an increase in intracellular Ca2+
concentration hyperpolarizes the endothelial cells leading to
activation of small (SKCa) and intermediate (IKCa) conductance
Ca2+-activated potassium channels on endothelial cells (Busse
et al., 2002; Gluais et al., 2005a; Edwards et al., 2010; channel
nomenclature follows Alexander et al., 2013). Activation of
these potassium channels in turn hyperpolarizes the vascular
smooth muscle either through the transfer of electrical signal-
ling via myoendothelial gap junctions (MEGJs) (Chaytor
et al., 1998; Edwards et al., 2000; Harris et al., 2000; Kenny
et al., 2002; Sandow et al., 2002; de Wit and Griffith, 2010;
Chadha et al., 2011; Kerr et al., 2012) or through efflux of K+
ions from endothelial SKCa and IKCa channels acting on
barium-sensitive inwardly rectifying potassium channels and
the ouabain-sensitive Na+/K+ ATPase pump respectively
(Edwards et al., 1998; 2010). Gap junctions are formed from
two docking hemichannels with each hemichannel made up
of six connexin (Cx) proteins (Griffith, 2004). In blood vessels,
four subtypes of Cx proteins have been identified, Cx 37, 40,
43 and 45 (Chaytor et al., 2003; Lang et al., 2007; de Wit and
Griffith, 2010). The Cx 43 subtype in particular has been
demonstrated to play a functional role in the EDH-mediated
vasorelaxation in subcutaneous resistance arteries from preg-
nant women (Lang et al., 2007).
In the second category of the EDH-mediated pathway,
smooth muscles cells are hyperpolarized by endothelium-
derived mediators (Edwards et al., 2010) such as H2O2
(Hayabuchi et al., 1998; Yada et al., 2003; Shimokawa, 2010)
or arachidonic acid derivatives (epoxyeicosatrienoic acids)
(Campbell et al., 1996). H2O2 has been reported to act as a
factor responsible for EDH in porcine coronary arteries
(PCAs), human, murine and rat mesenteric arteries (Matoba
et al., 2000; 2002; 2003; Wheal et al., 2012) (see Shimokawa,
2010). However, the responses to H2O2 may vary between
species, vascular beds and experimental conditions (Chaytor
et al., 2003; Gluais et al., 2005b; Lucchesi et al., 2005).
Cardiovascular risk in men and postmenopausal women is
higher than premenopausal women and sex differences in
endothelial function have been suggested to contribute to this
difference in risk (McCulloch and Randall, 1998; Villar et al.,
2008). To date, most studies on endothelial function have
been conducted on either arteries from male animals only
(Edwards et al., 1998; Harris et al., 2000; Matoba et al., 2003;
Leung et al., 2006; Garry et al., 2009) or from both sexes
(Quignard et al., 1999; Edwards et al., 2000; Yang et al., 2003;
Chadha et al., 2011; Huang et al., 2011). However, previous
studies have demonstrated clear sex differences in vascular
function of the EDH-mediated pathways (see Feletou and
Vanhoutte, 2006; Villar et al., 2008). EDH-mediated responses
have been reported to be up-regulated to compensate for the
loss of NO (McCulloch et al., 1997; Yada et al., 2003; Wheal
et al., 2012) and this compensation was greater in females than
males (McCulloch and Randall, 1998; White et al., 2000; Garry
et al., 2009). Furthermore, in endothelial NO synthase (eNOS)
and COX-1 double-knockout mice (‘EDH mice’), the male
mice were hypertensive while female mice were normotensive
with greater endothelium-dependent vasorelaxation in female
mice (Scotland et al., 2005). However, in rat cerebral arteries,
the EDH-mediated responses were greater in males compared
with females (Sokoya et al., 2007). In a previous study on
mesenteric arteries from rats, EDH-mediated responses in
females were partly dependent on increased expression of Cx
43, which was driven by oestrogen (Liu et al., 2002).
The aim of the present study was to investigate the effects
of sex on endothelium-dependent vasorelaxation of isolated
coronary arteries from male or female pigs (PCAs), specifically
the contributions of gap junction communication, endog-
enous H2O2 and Ca2+-activated K+ channels to the vasorelaxa-
tion induced by bradykinin.
Methods
Preparation of rings of distal PCAs
Hearts from male and female pigs (large white hybrid pigs,
4–6 months old, weighing ∼50 kg) were collected from a local
abattoir and transported to the laboratory in ice-cold modi-
fied Krebs’-Henseleit solution (118 mM NaCl, 4.8 mM KCl,
1.1 mM MgSO4, 25 mM NaHCO3, 1.2 mM KH2PO4, 12 mM
D-glucose, 1.25 mM CaCl2) previously gassed with 5% CO2
and 95% O2. The distal part of the coronary artery was then
dissected and placed in 2% w/v Ficoll in Krebs’-Henseleit
solution for overnight storage at 4°C. The following day,
tissues were finely dissected, cleaned of adherent connective
and fatty tissues. PCAs were then cut into rings of about
2 mm in length and mounted in a multichannel wire myo-
graph (Model 610 M, DMT, Aarhus N, Denmark) filled with
5 mL Krebs’-Henseleit solution gassed with 5% CO2 and
95% O2 and maintained at 37°C. Vessels were tensioned to
24.5 mN and left to equilibrate for approximately 30 min.
Tension was measured and recorded using a PowerLab record-
ing system (AD instruments, Oxfordshire, UK). The distal part
of the PCAs was used because it has previously been reported
that the EDH response is greater with decreasing vessel size
(Shimokawa et al., 1996) and the number of MEGJs appears to
be greater in the distal part of the rat mesenteric arteries,
compared with the proximal (Sandow and Hill, 2000). Here,
the mean vessel size of PCAs from female pigs (0.86 ±
0.02 mm) did not differ significantly from the mean vessel
size from male pigs (0.89 ± 0.02 mm) (two-tailed, unpaired
Student’s t-test). Seasonal variations in responses were not
allowed for the present study design but each set of experi-
ment has been carried out with an internal control.
Experimental protocol
Wire myography. After 30 min of equilibration, responses to
60 mM KCl were determined twice. The vascular tone was
then raised to about 50–80% of the second KCl contraction
tone by the addition of the thromboxane A2 mimetic, 9,11-
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dideoxy-9a,11a-epoxymethanoprostaglandin F2α (U46619;
2 nM–50 µM). Once stable tone was achieved, concentration-
response curves to bradykinin, an endothelium-dependent
relaxant (0.01 nM–1 µM) or NS309, (6,7-dichloro-1H-indole-
2,3-dione 3-oxime), a positive modulator of SKCa and IKCa
channels (Leuranguer et al., 2008; Dalsgaard et al., 2009;
Brondum et al., 2010) (0.1 µM–0.1 mM) were constructed. To
examine the selectivity of NS309, some experiments were
precontracted with 60 mM KCl with their respective controls
raised to the same tone with U46619. All inhibitors were
incubated with the tissues for 1 h before precontraction with
U46619. Vasorelaxation to bradykinin was studied in the
absence or presence of NG-nitro-L-arginine methyl ester
(L-NAME) (300 µM) which is a NO synthase inhibitor to
determine the NO-mediated component. Indomethacin
(10 µM) was used to inhibit the synthesis of prostanoids.
In some experiments, polyethelene glycol-catalase (PEG-
catalase; 300 U mL−1) (Hedegaard et al., 2011) was added to
remove intracellular H2O2. To study the role of gap junctions,
a non-selective gap junction inhibitor carbenoxolone
(100 µM) (Harris et al., 2002; Tang and Vanhoutte, 2008) or
18α-glycyrrhetinic acid (18α-GA) (100 µM) (Kenny et al.,
2002; Matoba et al., 2003) was used. Apamin (500 nM) and
TRAM-34 (10 µM) (Gluais et al., 2005a), SKCa and IKCa inhibi-
tors, respectively, were used to study the role of K+ channels
in the bradykinin-induced vasorelaxation.
Western blotting. Western blot studies were carried out to
determine the relative expression levels of Cx 37, 40, 43 and
IKCa in PCAs from male and female pigs. PCAs from male and
female pigs were finely dissected and cut into rings of about
1 cm in length. Vessels were then gassed with 5% CO2 and
95% O2 in Krebs’-Henseleit solution at 37°C for 1 h. Segments
(designated F1–F5 for samples from females and M1–M5 for
samples from males) were then homogenized on ice in lysis
buffer (80 mM sodium β-glycerophosphate, 20 mM imida-
zole, 1 mM dithiothreitol, 1 mM sodium fluoride, pH 7.6)
containing protease inhibitor cocktail (Calbiochem, VWR
International Ltd, Lutterworth, Leicestershire, UK). Samples
(F1–F5 and M1–M5) were diluted 1:1 in 2× Laemmli sample
buffer and heated at 95°C for 5 min. After centrifugation at
13 000× g for 1 min, 5 µg of protein were loaded on a 4–20%
Mini-PROTEAN TGX precast gel (Bio-Rad, Hemel Hempstead,
Hertfordshire, UK) and transferred onto nitrocellulose mem-
brane (GE Healthcare, Little Chalfont, Buckinghamshire, UK)
using a Bio-Rad mini-transblot. The nitrocellulose membrane
was then blocked with 5% w/v non-fat milk in Tris-buffered
saline containing 0.1% Tween 20 for 1 h before incubation
with mouse monoclonal anti-Cx-43 antibody (C8093 Sigma-
Aldrich) (1:1000) and mouse monoclonal anti-myosin light
chain (MLC) antibody (M4401 Sigma-Aldrich) (1:500) over-
night at 4°C. After washing in Tris-buffered saline containing
0.1% Tween 20, the blot was incubated with secondary anti-
body IRDye 800CW Goat anti-mouse IgG (1:10 000) (LI-COR
Biosciences, Cambridge, UK) at 37°C for 1 h. The immunob-
lot was then visualized using a LI-COR Odyssey Infrared
Imaging Scanner and the densities of bands determined using
Odyssey (Application Software 3.0 LI-COR Biosciences).
Due to the high concentration of proteins required for
all other antibodies, samples (designated F6–F10 and
M6–M10) were prepared in a slightly modified protocol.
Samples (F6–F10 and M6–M10) were homogenized on ice in
lysis buffer (20 mM Tris, 1 mM EGTA, 320 mM sucrose, 0.1%
Triton X100, 1 mM sodium fluoride, 10 mM sodium β-
glycerophosphate, pH 7.6) containing protease inhibitor
cocktail (Calbiochem) followed by centrifugation at 3000× g
for 5 min at 4°C. Supernatant of the samples were then solu-
bilized in 6× solubilization buffer and diluted to 1 mg mL−1 of
protein with 1× solubilization buffer. Samples were then
heated at 95°C for 5 min followed by centrifugation at
13 000× g for 1 min before loading to the precast gel. The
amounts of protein concentration loaded with the respective
dilution of antibody used were as followed: for Cx 40, 10 µg
of PCAs samples with 20 µg of pig kidney lysate used as
positive control were incubated with rabbit polyclonal
anti-Cx 40 – aminoterminal end antibody (ab38580 Abcam®,
Cambridge, UK) (1:100) and mouse monoclonal anti-GAPDH
antibody (G8795 Sigma-Aldrich, Poole, Dorset, UK)
(1:40 000). For Cx 37, 15 µg of PCAs samples with 20 µg of
pig and rat kidney lysate used as positive controls were incu-
bated with rabbit polyclonal anti-GJA4 antibody (C15878
Assay Biotech, Stratech Scientific Limited, Suffolk, UK)
(1:500) and mouse monoclonal anti-β-Actin antibody (A2228
Sigma-Aldrich) (1:40 000). For IKCa, 15 µg of PCAs samples
with 10 µg of pig kidney lysate used as positive control were
incubated with mouse polyclonal anti-KCNN4 antibody
(H00003783-B01P Abnova, Taipei, Taiwan) (1:500) and
mouse monoclonal anti-GAPDH antibody (G8795 Sigma-
Aldrich) (1:40 000). For all antibodies, the blocking and
washing steps used were as described above and the same
secondary antibody, IRDye® 800CW Goat anti-mouse IgG
(1:10 000) (LI-COR Biosciences) were used for anti-mouse
antibody and IRDye 680LT Goat anti-rabbit IgG (1:10 000)
(LI-COR Biosciences) for anti-rabbit antibody.
Data analysis
Data are presented as mean percentage relaxation of U46619-
induced tone with SEM and n being the number of separate
animals. The concentration-response curves were fitted to a
sigmoidal curve with a variable slope using four parameters
logistic equation in GraphPad Prism (Version 6, GraphPad
Software, La Jolla, CA, USA). The maximum percentage
relaxation (Rmax) and the negative log of concentration
required to produce half the maximal relaxation of the
induced tone (pEC50) were calculated from the fitted curves.
Data were analysed using two-tailed, paired or unpaired Stu-
dent’s t-test to compare differences between two groups. In
three or more groups, one-way ANOVA was used and significant
differences between groups were detected by Bonferroni’s post
hoc test. P-values of less than 0.05 were considered statisti-
cally significant.
Materials
All drugs were purchased from Sigma-Aldrich except for
apamin and NS309 from Tocris Bioscience (Bristol, UK). Stock
solutions of L-NAME, PEG-catalase, carbenoxolone and
apamin were made in distilled water. Stock solution of indo-
methacin was made in absolute ethanol whereas TRAM-34,
18α-GA and NS309 were dissolved in DMSO. Stock solutions of
bradykinin or the thromboxane A2 mimetic U46619 (10 mM)
were made in water and ethanol respectively. All further
dilutions of the stock solutions were made using distilled water
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except for NS309 which was further diluted with DMSO to
10 mM, 30% DMSO to 1 mM and distilled water to 0.1 mM.
Results
The effects of sex on EDH-type
vasorelaxations
In PCAs from male and female animals, bradykinin pro-
duced comparable, concentration-dependent vasorelaxant
effects, both in terms of the Rmax (Figure 1A) and the pEC50
values (8.50 ± 0.08 in females; 8.38 ± 0.08 in males). In
either set of PCAs, the addition of L-NAME and indometha-
cin reduced the maximum bradykinin-induced vasorelaxa-
tion compared with controls and this reduction was greater
in male than in female PCAs. The concentration-response of
arteries from both male and female pigs was also shifted
significantly to the right in the presence of L-NAME and
indomethacin, compared with their respective control
responses (pEC50 values: 7.65 ± 0.16, females; 7.33 ± 0.27,
Figure 1
Log concentration-response curves for the vasorelaxant effects of bradykinin in the absence or presence of 300 µM L-NAME and 10 µM
indomethacin in male and female PCAs (A). Data are expressed as a percentage change from U46619-induced tone and are mean ± SEM of 8–12
experiments. Original traces of recording showing the responses to increasing concentration of bradykinin (B,C). *P < 0.05, ****P < 0.0001;
significantly different as indicated; one-way ANOVA followed by Bonferroni’s post hoc test.
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males). Original traces of recording showing the tissue
responses with increasing concentrations of bradykinin are
shown in Figure 1B and C.
The effects of L-NAME, indomethacin and
PEG-catalase on bradykinin-induced
vasorelaxation in PCAs from male and
female pigs
In PCAs from females, treatment with PEG-catalase alone
(Figure 2A) significantly reduced the maximum vasorelaxa-
tion to bradykinin (with pEC50 = 8.23 ± 0.13), compared
with that under control conditions (with pEC50 = 8.46 ±
0.06). However, in the presence of L-NAME and indometha-
cin (pEC50 = 7.92 ± 0.2), no further inhibition of the Rmax was
observed when PEG-catalase was added (pEC50 = 7.63 ±
0.15).
Treatment of PCAs from males with PEG-catalase
(Figure 2B) did not affect Rmax to bradykinin (pEC50 = 8.05 ±
0.13) compared with control (pEC50 = 8.34 ± 0.09). The pres-
ence of L-NAME and indomethacin in male PCAs reduced the
vasorelaxant responses to bradykinin (pEC50 = 7.26 ± 0.30)
but the additional presence of PEG-catalase did not cause
further reductions (pEC50 = 7.07 ± 0.50).
The effects of L-NAME, indomethacin and
carbenoxolone on bradykinin-induced
vasorelaxation in PCAs from male and
female pigs
In PCAs from females, treatment with carbenoxolone alone
did not affect vasorelaxation to bradykinin, either as the
maximum response or as the pEC50 (Figure 3A). However, in
the presence of L-NAME and indomethacin (pEC50 = 7.92 ±
0.20), addition of carbenoxolone further reduced the
maximum relaxation to bradykinin (pEC50 = 7.62 ± 0.23).
In PCAs from males, the presence of carbenoxolone alone
or in combination with L-NAME and indomethacin did not
affect vasorelaxation to bradykinin (Figure 3B).
The effects of L-NAME, indomethacin
and 18α-GA on bradykinin-induced
vasorelaxation in PCAs from male and
female pigs
The addition of 18α-GA to PCAs from female pigs did not
affect bradykinin-induced vasorelaxation, compared with the
controls (Figure 4A). In the presence of L-NAME and indo-
methacin, addition of 18α-GA did not affect the Rmax but did
shift the curve to the right by 2.2-fold.
Figure 2
Log concentration-response curves for the vasorelaxant effects of bradykinin in the absence or presence of 300 µM L-NAME, 10 µM indomethacin
or 300 U mL−1 PEG-catalase in female (A) and in male (B) PCAs. Data are expressed as a percentage change from U46619-induced tone and are
mean ± SEM of 9–15 experiments. *P < 0.05; one-way ANOVA followed by Bonferroni’s post hoc test.
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In PCAs from male pigs (Figure 4B), presence of 18α-GA
alone had no effect on the bradykinin-induced vasorelaxa-
tion compared with the controls. Adding 18α-GA to L-NAME
and indomethacin also did not affect the bradykinin-induced
vasorelaxation.
The effects of L-NAME, indomethacin,
TRAM-34 and/or apamin on bradykinin-
induced vasorelaxation in PCAs from male
and female pigs
In PCAs from females, treatment with TRAM-34 in the pres-
ence of L-NAME and indomethacin (Figure 5A), inhibited the
maximum relaxation to bradykinin, without affecting pEC50
values (7.6 ± 0.05, without TRAM-34; 7.5 ± 0.2, with TRAM-
34) Similarly, the maximum relaxation to bradykinin was
inhibited by apamin in the presence of L-NAME and indo-
methacin (pEC50 = 7.6 ± 0.2) and the combination of channel
blockers produced a greater inhibition of the maximum
relaxation in the presence of L-NAME and indomethacin
(pEC50 = 7.2 ± 0.2) (Figure 5A).
In PCAs from males, vasorelaxation produced at 1 µM of
bradykinin was used for statistical analysis instead of Rmax
because the maximum relaxation was not fully defined in
some of the groups. Treatment with TRAM-34 in the presence
of L-NAME and indomethacin had no effect on the
bradykinin-induced vasorelaxation at 1 µM bradykinin com-
pared with L-NAME and indomethacin (Figure 5B). In con-
trast, addition of apamin alone significantly inhibited the
vasorelaxation produced at 1 µM bradykinin, compared with
L-NAME and indomethacin. Although adding both TRAM-34
and apamin, in the presence of L-NAME and indomethacin
inhibited the vasorelaxation to 1 µM bradykinin, compared
with that to L-NAME and indomethacin, this level of inhibi-
tion did not differ from that induced by apamin, L-NAME
and indomethacin.
The effects of L-NAME, indomethacin and
apamin and/or TRAM-34 on NS309-induced
vasorelaxation in PCAs from male and
female pigs
In PCAs from female (Figure 6A) and male (Figure 6B) pigs,
the presence of L-NAME and indomethacin, with or without
apamin, had no effect on the Rmax or pEC50 values (5.81 ± 0.05,
females; 5.82 ± 0.05, males) of the vasorelaxation induced by
the K+ channel opener, NS309. In PCAs from male pigs, in the
presence of L-NAME and indomethacin, the addition of
TRAM-34 did not affect responses to NS309 (Figure 6C), nor
did the combination of TRAM-34 with apamin (Figure 6D).
Figure 3
Log concentration-response curves for the vasorelaxant effects of bradykinin in the absence or presence of 300 µM L-NAME, 10 µM indomethacin
or 100 µM carbenoxolone in female (A) and in male (B) PCAs. Data are expressed as a percentage change from U46619-induced tone and are
mean ± SEM of 6–14 experiments. **P < 0.01, one-way ANOVA followed by Bonferroni’s post hoc test.
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On the other hand, in PCAs from female pigs, the presence of
L-NAME, indomethacin and both apamin and TRAM-34 sig-
nificantly inhibited the NS309-induced vasorelaxation
(Figure 6E) at 0.3 µM of NS309, with no differences in Rmax.
Additional experiments to test the selectivity of NS309
were carried out by precontracting vessels with either 60 mM
KCl or U46619 in the presence of L-NAME and indometha-
cin. As shown in Figure 6F, neither U46619 nor KCl affected
the maximum relaxation of NS309, but 60 mM KCl did shift
the concentration-response curve 8.1-fold to the right
(experimental record in Figure 6G).
Expression of Cx 37, 40 and 43 and IKCa in
PCAs from male and female pigs
Western blot analysis demonstrated the presence of Cx 43
(Figure 7A), Cx 40 (Figure 8A) and IKCa (Figure 10A), but not
Cx 37 (Figure 9A), proteins in PCAs from male and female
pigs. Further quantitative analysis based on the ratio of the
protein band intensities to their respective loading control
showed no significant differences between PCAs from male
and female pigs in Cx 43:MLC (Figure 7B), Cx 40:GAPDH
(Figure 8B) and IKCa : GAPDH (Figure 10B) (two-tailed,
unpaired Student’s t-test). In Figures 8A and 9, the red lower
band below 37 kDa is a non-specific band produced by the
secondary antibody, IRDye 680LT Goat anti-rabbit IgG
(1:10 000) (LI-COR Biosciences). For Cx 40 (Figure 8A), no
bands were observed at 40 kDa in the absence of the primary
antibody (data not shown).
Discussion and conclusions
In the present study, bradykinin-induced vasorelaxation in
PCAs from male and female pigs involved a substantial pro-
portion of the response which was resistant to the effects of
NO synthase inhibition and COX inhibition and this part of
the relaxation was therefore attributed to EDH (McCulloch
et al., 1997; Edwards et al., 2010). Here, we demonstrate a
significant sex difference in this EDH-mediated response
induced by bradykinin. Specifically, the EDH responses were
more prominent in female PCAs than in those from males.
Similar conclusions have been made in previous studies
including isolated mesenteric arteries from rats (McCulloch
and Randall, 1998; White et al., 2000), mesenteric arteries
from ‘EDH mice’ (eNOS/COX-1 double-knockout mouse) as
well as an in vivo study with ‘EDH mice’ (Scotland et al.,
2005). However, another study in PCAs reported that the
presence of L-NAME and indomethacin did not disclose any
significant sex differences in the endothelium-dependent vas-
orelaxation to bradykinin (Barber and Miller, 1997). This
Figure 4
Log concentration-response curves for the vasorelaxant effects of bradykinin in the presence of 300 µM L-NAME, 10 µM indomethacin and
100 µM 18α-glycyrrhetinic acid (18α-GA) in female (A) and in male (B) PCAs. Data are expressed as a percentage change from U46619-induced
tone and are mean ± S.E.M of six experiments. In female PCAs, presence of 18α-GA in L-NAME and indomethacin significantly shifted the
bradykinin-induced vasorelaxation curve 2.2-fold to the right.
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difference could possibly be due to the size of the vessels used.
In the present study, small distal PCAs where EDH is believed
to be more prominent in endothelium-dependent relaxations
(Shimokawa et al., 1996) were used. However, in the study
conducted by Barber and Miller (1997), the size of the vessels
used was not reported.
The present study also demonstrated that NO played a
greater role in PCAs from male pigs compared with female
pigs. This might have been due to a higher expression of
eNOS in males, compared with females, as a previous study in
rat thoracic aorta reported that the gene expression levels of
eNOS mRNA is higher in male rats compared with female rats
(Kerr et al., 1999). However, expression levels of eNOS alone
do not necessarily translate to activity and function of NO
because NO availability decreases rapidly as it reacts with
superoxide anion (O2–) forming peroxynitrite (Figure 11B)
(Kerr et al., 1999).
Another relevant endogenous mediator is H2O2, formed
by spontaneous or enzymic dismutation of O2– by superoxide
dismutase (SOD) (Figure 11A; Shimokawa, 2010). On its own,
H2O2 produced a concentration-dependent vasorelaxation
in PCAs (Matoba et al., 2003) and studies have reported
that H2O2 is a mediator (Matoba et al., 2000; 2002; 2003;
Shimokawa and Morikawa, 2005; Edwards et al., 2008;
Hammond et al., 2011) or modulator (Wheal et al., 2012) of
EDH. We therefore assessed the sex-related differences in
endothelium-derived H2O2 in PCAs. We found that PEG-
catalase alone significantly reduced vasorelaxation to brady-
kinin in PCAs from females but not males, suggesting that
endogenous H2O2 played a significant role only in the
responses of female PCAs. Conversely, in the presence of
L-NAME and indomethacin, PEG-catalase did not affect the
bradykinin-induced vasorelaxation in PCAs from both sexes,
indicating that H2O2 does not play a significant role in the
EDH-mediated pathway in distal PCAs. These findings differ
from a previous study conducted with male PCAs, which
concluded that H2O2 was an EDH mediator (Matoba et al.,
2003). In their study, porcine coronary microvessels (250–
300 µm in diameter) were used and endothelium-dependent
vasorelaxations to bradykinin were insensitive to indometha-
cin and L-NAME, which also differs from the findings in the
present study. These differences, or at least that in the absence
of NO and PGI2, could be due to the difference in vessel size
used. In the present study, experiments were repeated with a
higher concentration of PEG-catalase (600 U mL−1) in PCAs
from males, but no further inhibition of the bradykinin-
induced vasorelaxation was observed (data not shown).
Thus a relative lack of catalase is not likely to explain this
Figure 5
Log concentration-response curves for the vasorelaxant effects of bradykinin in the presence of 300 µM L-NAME, 10 µM indomethacin, 500 nM
apamin and/or 10 µM TRAM-34 in female (A) and in male (B). Data are expressed as a percentage change from U46619-induced tone and are
mean ± SEM of 5–11 experiments. *P < 0.05, **P < 0.01, ****P < 0.0001; one-way ANOVA followed by Bonferroni’s post hoc test.
BJP P S Wong et al.
2758 British Journal of Pharmacology (2014) 171 2751–2766
Figure 6
Log concentration-response curves for the vasorelaxant effects of NS309 in the presence of 300 µM L-NAME, 10 µM indomethacin and 500 nM
apamin in female (A) and in male (B) PCAs or 10 µM TRAM-34 in male (C) or both apamin and TRAM-34 in male (D) and female (E) PCAs. *P
< 0.05, two-tailed, paired Student’s t-test. To examine the selectivity of NS309, log concentration-response curves for the vasorelaxant effects of
NS309 in the presence of 300 µM L-NAME and 10 µM indomethacin precontracted with either U46619 or 60 mM KCl in female PCAs (F) was
constructed where presence of 60 mM KCl significantly shifted the NS309-induced vasorelaxation 8.1-fold to the right (P < 0.001, two-tailed,
paired Student’s t-test). Data are expressed as a percentage change from U46619-induced tone and are mean ± SEM of five to ten experiments.
Original traces of recording showing the responses to increasing concentration of NS309, a selective SKCa and IKCa channels activator (G).
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discrepancy. Another source of endothelium-derived H2O2 is
the O2− generated as a by-product from the conversion of
L-arginine to NO by eNOS (Figure 11A) (Heinzel et al., 1992).
Previous studies have reported that L-NAME caused a reduc-
tion in O2− generation (Kerr et al., 1999) and inhibition of
H2O2 formation (Heinzel et al., 1992). Therefore, it is possible
that formation of endogenous H2O2 in distal PCAs (as used in
the present study) was dependent on the eNOS system where
formation of H2O2 would also be inhibited in the presence of
L-NAME. However, it should be noted that all our experi-
ments were conducted in the presence of both L-NAME and
indomethacin, and therefore the contribution of the COX-
prostanoid pathway to the formation of H2O2 and its effects
cannot be excluded.
On the other hand, in the NO-mediated response, a
higher level of NO in PCAs from males could have reacted
with O2–, forming peroxynitrite rather than H2O2, as the reac-
tion of O2– with NO is three to four times faster than that with
SOD (Wolin, 2009). This might explain why H2O2 did not
play a role in the NO-mediated pathway in males. As for
the response observed in PCAs from female pigs where
endothelium-derived H2O2 was involved in the NO-mediated
bradykinin-induced vasorelaxation, we propose that there
may be a higher level of SOD present in the endothelial cells
in female PCAs, leading to H2O2 formation. A previous study
in mitochondria isolated from rat brain and liver showed
higher expression and activities of manganese-SOD and glu-
tathione peroxidase in females compared with males, thus
providing a protective effect in females during oxidative
stress (Borras et al., 2003). However, further studies to deter-
mine the SOD levels and activity in PCAs are required. Also,
as O2– in the blood vessels can be generated from several
Figure 6
Continued
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different pathways (Wolin, 2009) including NAPDH oxidase,
it is possible that there are sex differences in the upstream
reactions. Previous studies in age-matched rat aorta (Brandes
and Mugge, 1997) and in young healthy human subjects (Ide
et al., 2002) concluded that males experience a greater oxida-
tive stress compared with females and this was attributed to
the increased production of O2− and reduced activity or avail-
ability of O2− scavengers.
Next, we investigated the role of gap junctional commu-
nication in male and female arteries as it has been reported
that gap junctions play a role in the EDH-mediated response.
We examined the effects of two different inhibitors (car-
benoxolone and 18α-GA) alone or in combination with
L-NAME and indomethacin against bradykinin-induced vas-
orelaxation. In PCAs from male and female pigs, the presence
of carbenoxolone or 18α-GA alone had no effect on vasore-
laxation to bradykinin indicating that gap junctional
communication did not play a significant role in the
NO-mediated response. Conversely, in the EDH pathway, car-
benoxolone significantly reduced the maximum relaxation to
bradykinin in PCAs from female but not male pigs. The
inhibitory effects of both carbenoxolone and 18α-GA in the
presence of L-NAME and indomethacin confirmed that gap
junction communication played a significant role in the EDH
responses induced by bradykinin in PCAs from female pigs
but not male pigs. These findings concur with previous
studies on isolated myometrial arteries and subcutaneous
resistance arteries from pregnant women (Kenny et al., 2002;
Lang et al., 2007) while the finding in PCAs from male pigs is
in agreement with a previous study using 18α-GA in PCAs
from male pigs (Matoba et al., 2003). Gap junctions have
been reported to play a role in both NO-dependent and
EDH-mediated endothelium-dependent vasorelaxation in
mesenteric arteries and thoracic aortae from male rabbits
(Chaytor et al., 1998), human mesenteric arteries (Chadha
et al., 2011) and PCAs of unspecified sex (Edwards et al.,
2000). However, another study conducted on PCAs of
unspecified sex using three different types of gap junction
inhibitors (18α-GA, 1-heptanol and Gap27) had no effect on
the EDH response (Yang et al., 2003). In the NO-dependent
responses of the present study, the difference in findings
could be due to the difference in the size and/or type of
vascular tissue used or species differences (Feletou and
Vanhoutte, 2006). The inconsistency of findings for the role
of gap junctions in all previous studies could possibly be due
to the unspecified sex used (Yang et al., 2003; Chadha et al.,
2011).
We have now demonstrated clear sex differences in the
role of gap junctional communication in EDH responses. As
Cx 43 has previously been implicated in EDH-mediated
relaxations (Lang et al., 2007), we investigated whether dif-
ferential expression of this protein could explain the differ-
ence in the sensitivity to gap junction inhibition. However,
Figure 7
Connexin 43 (43 kDa) and MLC (18 kDa) expression levels in 5 µg of
female (F1–F5) and male PCAs (M1–M5) (A). Ratio of the expression
levels of connexin 43 to MLC in male and female PCAs based on the
intensities of their bands (B). Data are expressed in the ratio of Cx43
to MLC intensities bands and are mean ± SEM of five experiments.
Figure 8
Connexin 40 (40 kDa) and GAPDH (∼37 kDa) expression levels in
10 µg of female (F6–F10) and male PCAs (M6–M9) with 20 µg of pig
kidney (PK) lysate as positive control (A). Ratio of the expression
levels of connexin 40 to GAPDH in male and female PCAs based on
the intensities of their bands (B). Data are expressed in the ratio of
Cx40 to GAPDH intensities bands and are mean ± SEM of four to five
experiments.
Figure 9
Connexin 37 (∼37 kDa) and β-actin (42 kDa) expression levels in
15 µg of female (F7–F9) and male PCAs (M6–M8) with 20 µg of pig
(PK) and rat kidney (RK) lysate as positive controls.
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in the present study, our Western blot analysis for Cx 43
protein in PCAs from male and female pigs did not detect any
differences, indicating that expression per se did not contrib-
ute to the sex differences observed. Further, Western blot
analysis on other subtypes of Cx proteins that have been
previously identified in blood vessels (Chaytor et al., 2003;
Lang et al., 2007; de Wit and Griffith, 2010) showed no dif-
ferences in the expression level of Cx 40 proteins and we
could not detect Cx 37 proteins in PCAs from male and
female pigs. Therefore, the differences in EDH-mediated
responses between PCAs from male and female pigs may be
due to differences in the operation of the gap junctions,
rather than the expression of gap junction proteins. One
possibility is that calcium-activated potassium channels (Kca)
(Gluais et al., 2005a; Chadha et al., 2011) which are located
near the MEGJs differentially influence gap junctional com-
munication, in males and females.
Given the potential differences in KCa-channel activity
between sexes, we then examined the effects of apamin, the
SKCa blocker and the TRAM-34, an inhibitor of IKCa channels
on EDH-mediated responses (Yang et al., 2003; Gluais et al.,
2005a; Edwards et al., 2010; Chadha et al., 2011). Here, we
demonstrated that in the EDH-mediated response, IKCa chan-
nels played a role only in PCAs from female pigs, while the
SKCa channels play a role in both sexes. This is in agreement
with a previous study conducted on carotid arteries from
male guinea pigs where TRAM-34 alone had no effect on
endothelium-dependent hyperpolarization, but apamin sig-
nificantly inhibited acetylcholine-evoked hyperpolarization
(Gluais et al., 2005a). Furthermore, another study examining
sex differences in EDH-mediated responses reported that
apamin had the same effect on the maximum relaxation to
acetylcholine in male and female rat mesenteric arteries
(White et al., 2000), which is comparable with the present
study. Taken together, the present study demonstrates that
gap junctional communication and IKCa channels play a role
in the EDH-mediated response in PCAs from females, but not
males. Interestingly, previous studies using immunohisto-
chemistry with specific antibodies showed that IKCa channels
are colocalized with myoendothelial Cx proteins with their
function being related to the EDH-mediated activity (Sandow
et al., 2006; Chadha et al., 2011). A previous study in male
obese rats demonstrated an up-regulation in IKCa and MEGJ
expression and activity to compensate for the loss of
NO-mediated responses as observed in male age-matched
control rats (Chadha et al., 2010). However, Western blot
analysis in the present study for IKCa expression level showed
no sex-related differences between PCAs.
In order to determine whether there is a difference in the
function of IKCa channels between males and females, NS309
was used as a potent and selective SKCa and IKCa channel
activator (Leuranguer et al., 2008). NS309 produced a compa-
rable concentration-dependent vasorelaxation in male and
female PCAs. Blocking SKCa channels specifically with apamin
had no effect on the NS309-induced vasorelaxation in either
male or female pigs. Further experiments blocking IKCa chan-
nels specifically with TRAM-34 also had no effect on the
NS309-induced vasorelaxation. This finding is in line with a
previous study measuring the membrane potential of guinea
pig carotid arteries where NS309 (10 µM)-induced hyperpo-
larization was not significantly affected by TRAM-34 or
apamin alone in the presence of L-NAME and indomethacin.
It is therefore possible that when either SKCa or IKCa channels
are blocked separately, there is a compensatory response
Figure 10
IKCa (47.5 kDa) and GAPDH (∼37 kDa) expression levels in 15 µg of female (F6–F10) and male PCAs (M6–M10) with 10 µg of pig kidney (PK) lysate
as positive control (A). Ratio of the expression levels of IKCa to GAPDH in male and female PCAs based on the intensities of their bands (B). Data
are expressed in the ratio of IKCa to GAPDH intensities bands and are mean ± SEM of five experiments.
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involving the other KCa channels activated by NS309.
However, blocking both SKCa and IKCa channels had little
effect on the NS309-induced vasorelaxation, although there
was slight inhibition at 0.3 µM in PCAs from female pigs.
These data suggest that NS309 is not mediating relaxation
through SKCa or IKCa channels in the PCA and therefore
cannot be used to determine if there is a difference in the
activity of these channels between males and females. Addi-
tional experiments to investigate the selectivity of NS309
using high potassium demonstrated that at higher concen-
trations of NS309 (>3 µM), other vasorelaxation pathways
may be involved. This observation is in line with previous
Figure 11
Hypothesized mechanism of action of sex differences in endothelial function underlying bradykinin-induced vasorelaxation in isolated PCAs from
female (A) and male (B) pigs. Present study demonstrated a clear sex differences in endothelial function where only in PCAs from female pigs have
greater EDH-mediated responses specifically the gap junction communication whereas endogenous H2O2 plays a role in the NO-mediated
pathway in female pigs. Figure adapted from Shimokawa (2010).
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studies where loss of selectivity for IKCa and SKCa has been
reported at higher concentrations of NS309 (Dalsgaard et al.,
2009; Kroigaard et al., 2012). Furthermore, NS309 inhibited
voltage-dependent Ca2+ channels (Morimura et al., 2006).
Therefore, in the present study, use of NS309 as a selective
activator of SKCa and IKCa is questionable and it may not
be appropriate to draw any conclusions to support the
bradykinin-induced vasorelaxation findings. To our knowl-
edge, NS309 is a more potent and selective SKCa and IKCa
activator compared with other activators such as 1-ethyl-2-
benzimidazolinone (Leuranguer et al., 2008) or 5,6-dichloro-
1-ethyl -1,3-dihydro-2H-benzimidazole-2-one (Morimura
et al., 2006).
In conclusion, the present study demonstrates that both
NO and EDH-mediated responses contribute significantly
towards the endothelium-dependent vasorelaxation induced
by bradykinin in male and female isolated distal PCAs. Clear
sex differences in endothelial function have been demon-
strated where the EDH-mediated responses play a greater role
in PCAs from female compared with male pigs. In PCAs from
females, endogenous H2O2 played a role in the bradykinin-
induced vasorelaxation. Furthermore, gap junctional com-
munication and the IKCa channels appear to be more
important in the EDH-mediated pathway in PCAs from
females and this could be compensation for the diminished
response of a NO-mediated pathway in these PCAs. The sex
differences in endothelial function demonstrated in the
present study may contribute to a better understanding of the
cardiovascular protective effects observed in premenopausal
women.
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